english

EU drug regulator finds possible link between J&J Covid vaccine and rare deep-vein blood clotting cases

The European Medicines Agency (EMA) has announced a possible link between the Johnson & Johnson (J&J) Covid vaccine and rare cases of blood clotting in deep veins, recommending it be listed as a potential side effect to the jab. 

After a meeting of its Pharmacovigilance Risk Assessment Committee (PRAC), the drug regulator said on Friday that venous thromboembolism, a potentially life-threatening blood clotting condition, should be added to the J&J vaccine’s product label as a rare possible side effect. The illness causes a clot to form in the vein of a leg, arm, or the groin, which can then travel to the lungs and cut off the blood supply.

Alongside the blood clotting concern, the EMA warned that immune thrombocytopenia, a disorder that causes the body to mistakenly attack its own blood platelets, should be added to the drug’s potential side effects. It also recommended adding it as a possible adverse reaction to AstraZeneca’s Covid vaccine.

This is not the first time that J&J has been advised to add a blood clotting risk as a potential side effect, with the PRAC previously highlighting the potential link between the company’s vaccine and cerebral venous sinus thrombosis, as well as splanchnic vein thrombosis – clots that target the brain and the abdomen respectively. 

Also on rt.com

Doses of Johnson & Johnson coronavirus vaccines are seen in a mass vaccination site. © Reuters / Marco Bello
Slovenia suspends Johnson & Johnson vaccine after young woman’s death

The EMA did not announce any change to its previous risk assessment of the J&J vaccine, which stated that the positives outweigh the potential risks, giving European nations the green light to use the jab.

Responding to the EMA’s updates on Friday, J&J said that it would update its product information accordingly, while noting that the chances of such conditions are very low.

Like this story? Share it with a friend!

source: RT




Împotriva articolelor redacției noastre, persoanele nemulțumite pot formula Contestație în termen de 10 zile de la publicarea articolului, la judecătoria Orășenească nr. 1 München Bayern Deutschland, in conformitate cu Legea federală Germană. Considerăm că nu se pot formula acțiuni la instanțele din România deoarece nici o persoană care activează în trustul nostru nu poate fi extrasă de sub jurisdicția federală germană. Considerăm că redacția noastră nu răspunde în fața autorităților din România ci doar celor federale sau civile germane. deoarece legea română nu are efecte de extraneitate asupra redacției chiar dacă subiectul știrilor face obiectul unor evenimente sau persoane din România și sunt scrise în limba română. Limba română nu este izvor de extraneitate a legii.

(Visited 20 times, 1 visits today)
Avatar
Marius Leontiuc
absolvent WEB DESIGN Academia Britanică de Comunicare Iasi - absolvent COMUNICARE IN AFACERI Academia Britanica de Afaceri si Comunicare -absolvent JURNALISM EDITORIAL - London School University - 2019 inscris la echivalare diploma la Universitatea Politehnica Timisoara - absolvent studii de Drept Universitatea Europeană Drăgan, cursuri in Drept la Universitatea de Vest Timisoara, absolvent studii de proiectare, pastor coordonator in Biserica Protestanta Evanghelica, Android Developer pe Google Play și plugin developer la Oxwall, creator de teme Wordpress și Oxwall, operator Wordpress, Drupal, Oxwall, Osclass, Moodle, tehnologii HTML și PHP
http://www.leontiucmarius.wordpress.com/cv

Lasă un răspuns

Adresa ta de email nu va fi publicată. Câmpurile obligatorii sunt marcate cu *